A detailed history of State Of Wisconsin Investment Board transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 39,114 shares of STOK stock, worth $456,851. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,114
Previous 40,602 3.66%
Holding current value
$456,851
Previous $548,000 12.41%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$12.24 - $15.92 $18,213 - $23,688
-1,488 Reduced 3.66%
39,114 $480,000
Q2 2024

Aug 14, 2024

SELL
$11.03 - $17.52 $83,805 - $133,116
-7,598 Reduced 15.76%
40,602 $548,000
Q1 2024

May 14, 2024

SELL
$4.12 - $14.17 $158,208 - $544,128
-38,400 Reduced 44.34%
48,200 $650,000
Q4 2023

Feb 12, 2024

BUY
$3.37 - $5.4 $23,846 - $38,210
7,076 Added 8.9%
86,600 $455,000
Q3 2023

Nov 14, 2023

SELL
$3.78 - $11.99 $27,771 - $88,090
-7,347 Reduced 8.46%
79,524 $313,000
Q2 2023

Aug 14, 2023

BUY
$7.93 - $13.82 $148,100 - $258,102
18,676 Added 27.39%
86,871 $923,000
Q1 2023

May 15, 2023

BUY
$7.65 - $10.38 $182,452 - $247,563
23,850 Added 53.78%
68,195 $568,000
Q4 2022

Feb 14, 2023

BUY
$7.07 - $15.69 $205,843 - $456,814
29,115 Added 191.17%
44,345 $409,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $22.53 $12,195 - $21,876
971 Added 6.81%
15,230 $196,000
Q2 2022

Aug 15, 2022

SELL
$10.36 - $23.93 $266,676 - $615,982
-25,741 Reduced 64.35%
14,259 $188,000
Q1 2022

May 13, 2022

BUY
$17.19 - $26.1 $390,213 - $592,470
22,700 Added 131.21%
40,000 $842,000
Q4 2020

Feb 03, 2021

SELL
$33.62 - $61.93 $73,964 - $136,246
-2,200 Reduced 11.28%
17,300 $1.07 Million
Q2 2020

Aug 12, 2020

BUY
$20.26 - $29.73 $109,404 - $160,542
5,400 Added 38.3%
19,500 $465,000
Q1 2020

May 06, 2020

BUY
$16.8 - $34.15 $3,360 - $6,830
200 Added 1.44%
14,100 $323,000
Q3 2019

Nov 12, 2019

BUY
$20.53 - $37.72 $285,367 - $524,308
13,900 New
13,900 $299,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $460M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.